Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 122614
Published online Nov 27, 2026. doi: 10.4240/wjgs.122614
Published online Nov 27, 2026. doi: 10.4240/wjgs.122614
Table 6 Multivariate analysis
| Variable | β | SE | Wald | P value | OR | 95%CI |
| Age (years) | 0.716 | 0.446 | 2.573 | 0.109 | 2.046 | 0.853-4.909 |
| TNM staging | 1.367 | 0.545 | 6.292 | 0.012 | 3.922 | 1.348-11.408 |
| Surgical duration (hours) | 0.747 | 0.451 | 2.741 | 0.098 | 2.110 | 0.872-5.106 |
| Baseline gastrin (ng/L) | -0.796 | 0.433 | 3.385 | 0.066 | 0.451 | 0.193-1.053 |
| Baseline motilin (mg/L) | -1.374 | 0.456 | 9.063 | 0.003 | 0.253 | 0.104-0.619 |
| Therapeutic regimen | -1.172 | 0.449 | 6.801 | 0.009 | 0.310 | 0.128-0.747 |
- Citation: Zhu SL, Gao Q, Liu Y, Cheng KP. Omeprazole-cisapride combination for gastroparesis following radical gastrectomy for gastric cancer: An efficacy and safety analysis. World J Gastrointest Surg 2026; 18(11): 122614
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/122614.htm
- DOI: https://dx.doi.org/10.4240/wjgs.122614